Académique Documents
Professionnel Documents
Culture Documents
Heart disease is the number one killer of both men and women in the
United States, yet its long been considered a mans disease in the
popular imagination. This perception likely stems, in part, from the
fact that coronary heart disease, the most common cause of heart
attacks, is more prevalent among men and tends to strike them at a
younger age. When younger women do have heart attacks, though,
studies have found that they are about twice as likely to die as their
male counterparts and more than 15,000 women under the age of
55 do every year.
For decades, studies have attempted to tease out the various factors
that may contribute to that signicant gender gap. Recently,
researchers at the Yale School of Public Health published a qualitative
study exploring the experiences of women under the age of 55 who
had been hospitalized for a heart attack. The main take-away
according to most headlines summing up the results seems to be
that younger women may ignore or dismiss their symptoms and
hesitate or delay in seeking care, in part out of anxiety about
raising a false alarm.
. . .
Of course, the fact that womens heart attacks are less likely to adhere
to the textbook model is not exactly an accident, since the textbook
was, quite literally, written based on what mens heart attacks look
like. Though theres been slight improvement since the National
Institutes of Health Revitalization Act mandated proportional
representation of women and minorities in clinical trials in 1993,
recommendations for preventing, diagnosing, and treating heart
disease continue to be largely extrapolated from research conducted
on white, middle-age men. A review of the American Heart
Associations 2007 prevention guidelines for women, for example,
found that they drew on studies in which women made up only 30
percent of the subject population. Only one third of the studies even
broke down the results by gender.
What modest progress has been made in closing this gender gap in
the clinical studies has led to some real shifts in practice and
probably contributed to the decline in cardiovascular-related mortality
rates, especially pronounced among women, since 2000. Last year, the
American Heart Association credited recent gender-specic research
with improving the diagnostic processes for non-obstructive coronary
heart disease in women. For decades, doctors used the male model of
coronary heart disease testing to identify the disease in women,
automatically focusing on the detection of obstructive coronary artery
disease, AHA cardiologist Jennifer H. Mieres explained at the time.
As a result, symptomatic women who did not have classic obstructive
coronary disease were not diagnosed with ischemic heart disease, and
did not receive appropriate treatment, thereby increasing their risk for
heart attack.
In all likelihood its mostly thanks to these improvements in catching
and managing coronary heart disease before it causes a heart attack
that the mortality gap between younger women and men has begun
to narrow in recent years. Its less clear if health care providers have
become any better at recognizing and quickly responding to heart
attacks in women when it does get to that point. Like their patients,
doctors remain slower to act when symptoms dont conform to the
classic model. A 2012 study that tracked more than 1.1 million heart
attack patients from 1994 to 2006 concluded that this helped explain
why 15 percent of the women died in the hospital, compared to 10
percent of the men. Patients who never experienced chest pain were
nearly twice as likely to die, due in part to delays in getting life-saving
interventions. And women, particularly younger women, were
overrepresented in this group: 42 percent of the women didnt have
chest pain, compared to only 31 percent of the men.
. . .
That was when the patients did experience the classic heart attack
symptoms. In the next twist on the study, the researchers asked 142
family physicians to assess a male and female patient presenting with
atypical symptoms, including nausea and back pain. This muddied the
picture further: The woman was slightly less likely than the man to
receive a heart disease diagnosis, but neither was likely to get one at
all. And when stress was added to the mix, both men and women
became even more likely to be diagnosed with a gastrointestinal
problem instead. Given that women more commonly have both
atypical symptoms and signs of anxiety, the end result is, yet again,
that women are left under-diagnosed.
Thats what a 2014 study looking at over 1,000 patients, aged 18 to 55,
who had heart attacks in Canada, the United States, and Switzerland,
suggests. The study found that men received faster access to cardiac
testing and care than women; the average time it took for men to get
an electrocardiogram, for example, was 15 minutes, compared to 21
minutes for women. While some factors including an absence of
chest pain seemed to cause delays in both genders, anxiety was
associated with the failure to meet the 10-minute benchmark for ECG
only in treating female patients. The researchers also gave the
patients a personality test gauging how closely they adhered to
traditional gender roles and found that both men and women with
more stereotypically feminine traits faced more delays than patients
with masculine traits.
. . .
This pervasive bias may simply be easier to see in the especially high-
stakes context of a heart attack, in which the true cause usually
becomes crystal clear too often tragically in a matter of hours or
days. When it comes to less acute problems, the eect of such medical
gaslighting is harder to quantify, as many women either accept
misdiagnoses or persist until they nd a health care provider who
believes their symptoms arent just in their head. But it can be
observed indirectly: In the ever-increasing numbers of women
prescribed anti-anxiety meds and anti-depressants. In the fact that
women make up the majority of the 100 million Americans suering
from (often under-treated) chronic pain. In the fact that it takes
nearly ve years and ve doctors, on average, for patients with
autoimmune diseases, more than 75 percent of whom are women, to
receive a proper diagnosis, and that half report being labeled chronic
complainers in the early stages of their illness. Then there are the
diseases, like chronic fatigue syndrome and bromyalgia, that exist so
squarely at the overlap of the Venn diagrams of aects mostly
women and unknown etiology that theyve only recently begun to
be recognized as real diseases at all.
And it can be seen, too, in the women who simply disengage from the
system altogether. In the Yale study, interviewees reported limited
and sporadic connections with primary care for routine check-ups
and preventive heart care. In part, this was due to structural barriers
such as lack of insurance and little time between work and family
responsibilities that other research has found tend to
disproportionately aect women. But some interviewees also
explained that they were concerned about being perceived as
complaining about minor concerns and had had negative experiences
with health care providers in the past: poor physician-patient
relationships, feeling rebued or treated with disrespect, and being
denied care. Its hardly surprising that many also reported being
hesitant to seek help when they suspected they might be having a
heart attack for fear of being perceived as hypochondriacal.
This fear didnt fall out of the sky. And while it cant be blamed solely
on the health care system, it also cant be separated from the medical
establishments systemic failures to study, understand, and take
seriously womens health concerns.
Call me crazy hysterical, even but I dont think you should have to
feel that empowered just to receive proper medical treatment.
The Gender Gap explores the persisting gender inequalities of the modern
age and societys unwillingness to grapple with them.